JP2014534169A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014534169A5 JP2014534169A5 JP2014531256A JP2014531256A JP2014534169A5 JP 2014534169 A5 JP2014534169 A5 JP 2014534169A5 JP 2014531256 A JP2014531256 A JP 2014531256A JP 2014531256 A JP2014531256 A JP 2014531256A JP 2014534169 A5 JP2014534169 A5 JP 2014534169A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- amino acid
- acid sequence
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 125000003275 alpha amino acid group Chemical group 0.000 description 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11182598 | 2011-09-23 | ||
| EP11182598.0 | 2011-09-23 | ||
| US201161545763P | 2011-10-11 | 2011-10-11 | |
| US61/545,763 | 2011-10-11 | ||
| PCT/EP2012/068703 WO2013041707A1 (en) | 2011-09-23 | 2012-09-21 | Peptide or arrangement of peptides forming a staphylococcus aureus epitope binding site |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014534169A JP2014534169A (ja) | 2014-12-18 |
| JP2014534169A5 true JP2014534169A5 (OSRAM) | 2017-02-16 |
Family
ID=47913924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014531256A Ceased JP2014534169A (ja) | 2011-09-23 | 2012-09-21 | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓエピトープ結合部位を形成するペプチドまたはペプチドの配置 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9422365B2 (OSRAM) |
| EP (1) | EP2758431A1 (OSRAM) |
| JP (1) | JP2014534169A (OSRAM) |
| CN (1) | CN103857697A (OSRAM) |
| AU (1) | AU2012311428A1 (OSRAM) |
| WO (1) | WO2013041707A1 (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104987416A (zh) | 2008-05-23 | 2015-10-21 | Siwa有限公司 | 促进再生的方法、组合物及设备 |
| US8721571B2 (en) | 2010-11-22 | 2014-05-13 | Siwa Corporation | Selective removal of cells having accumulated agents |
| US9944694B2 (en) * | 2013-12-13 | 2018-04-17 | Rijksuniversiteit Groningen | Antibodies against Staphylococcus aureus and uses therof |
| RU2721568C2 (ru) | 2014-09-19 | 2020-05-20 | Сива Корпорейшн | Анти-age антитела для лечения воспаления и аутоиммунных нарушений |
| US10358502B2 (en) | 2014-12-18 | 2019-07-23 | Siwa Corporation | Product and method for treating sarcopenia |
| US9993535B2 (en) | 2014-12-18 | 2018-06-12 | Siwa Corporation | Method and composition for treating sarcopenia |
| AU2017219749B2 (en) | 2016-02-19 | 2022-01-06 | Siwa Corporation | Method and composition for treating cancer, killing metastatic cancer cells and preventing cancer metastasis using antibody to advanced glycation end products (AGE) |
| WO2017181116A1 (en) | 2016-04-15 | 2017-10-19 | Siwa Corporation | Anti-age antibodies for treating neurodegenerative disorders |
| JP2019518763A (ja) | 2016-06-23 | 2019-07-04 | シワ コーポレーション | 様々な疾患及び障害の治療において使用するためのワクチン |
| US10961321B1 (en) | 2017-01-06 | 2021-03-30 | Siwa Corporation | Methods and compositions for treating pain associated with inflammation |
| US10995151B1 (en) * | 2017-01-06 | 2021-05-04 | Siwa Corporation | Methods and compositions for treating disease-related cachexia |
| US10925937B1 (en) | 2017-01-06 | 2021-02-23 | Siwa Corporation | Vaccines for use in treating juvenile disorders associated with inflammation |
| US10858449B1 (en) * | 2017-01-06 | 2020-12-08 | Siwa Corporation | Methods and compositions for treating osteoarthritis |
| US10919957B2 (en) | 2017-04-13 | 2021-02-16 | Siwa Corporation | Humanized monoclonal advanced glycation end-product antibody |
| US11518801B1 (en) | 2017-12-22 | 2022-12-06 | Siwa Corporation | Methods and compositions for treating diabetes and diabetic complications |
| CN109021109A (zh) * | 2018-07-20 | 2018-12-18 | 上海交通大学 | 一种牛源性抗金黄色葡萄球菌融合抗体scFv-Fc及其制备方法 |
| CN119431528B (zh) * | 2024-10-28 | 2025-10-14 | 中国人民解放军陆军军医大学 | 一种金黄色葡萄球菌毒素LukG抗原表位肽及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002072600A2 (en) * | 2001-01-26 | 2002-09-19 | Inhibitex, Inc. | Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| JP2009031009A (ja) * | 2007-07-24 | 2009-02-12 | St Marianna Univ School Of Medicine | 黄色ブドウ球菌の検出または同定方法および検出キット |
| CN102695724B (zh) * | 2009-05-18 | 2016-08-24 | 维尔茨堡尤利乌斯·马克西米利安大学 | 指向金黄葡萄球菌表位isaa或isab的抗体或其片段 |
-
2012
- 2012-09-21 AU AU2012311428A patent/AU2012311428A1/en not_active Abandoned
- 2012-09-21 WO PCT/EP2012/068703 patent/WO2013041707A1/en not_active Ceased
- 2012-09-21 JP JP2014531256A patent/JP2014534169A/ja not_active Ceased
- 2012-09-21 CN CN201280046452.2A patent/CN103857697A/zh active Pending
- 2012-09-21 EP EP12759781.3A patent/EP2758431A1/en not_active Withdrawn
- 2012-09-21 US US14/346,435 patent/US9422365B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014534169A5 (OSRAM) | ||
| HRP20240719T1 (hr) | Kimerna i humanizirana monoklonska protutijela protiv ljudskog ctla4 i njihova upotreba | |
| JP2011173914A5 (OSRAM) | ||
| TWI732136B (zh) | 新型雙特異性cd3/cd19多肽複合物 | |
| CN108064240B (zh) | 针对流感血凝素的人抗体 | |
| AR124676A2 (es) | Formulación farmacéutica que comprende una droga biofarmacéutica | |
| JP2017071606A5 (OSRAM) | ||
| JP2014519318A5 (OSRAM) | ||
| PE20190920A1 (es) | Anticuerpos modificados de union a fcrn humano y metodos de utilizacion | |
| EP2581113A4 (en) | ANTI-TIM-3 ANTIBODY | |
| NZ715896A (en) | Humanized or chimeric cd3 antibodies | |
| CR20140029A (es) | Proteínas de unión a antígeno de tnf-alfa con unión a fcrn incrementada | |
| JP2016529229A5 (OSRAM) | ||
| CN103717263A (zh) | 结合ox40的抗体及其用途 | |
| UA114891C2 (uk) | ІЗОЛЬОВАНЕ АНТИТІЛО ЛЮДИНИ, ЯКЕ СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З АНГІОПОЕТИНПОДІБНИМ БІЛКОМ 3 ЛЮДИНИ (hАNGPTL3), ТА ЙОГО ЗАСТОСУВАННЯ | |
| EA202091590A1 (ru) | Антитела против pd-l1 и варианты их применения | |
| EA201992760A3 (ru) | Жидкая композиция белкового конъюгата, содержащего оксинтомодулин и фрагмент иммуноглобулина | |
| EP2543727A4 (en) | MODIFIED ANTIBODY COMPOSITION | |
| EA202191359A1 (ru) | Антагонистические моноклональные антитела к cd40 и их применения | |
| SI2542257T1 (en) | Optimized monoclonal antibodies against Tissue Factor Pathway Inhibitor (TFPI) | |
| JP2016512430A (ja) | Ｎａｖ１．７に対するヒト抗体 | |
| JP2010526028A5 (OSRAM) | ||
| WO2014114651A9 (en) | Tnf-alpha antigen-binding proteins | |
| RU2017145268A (ru) | Композиции и способы диагностики и лечения заболеваний, ассоциированных с дегенерацией нейритов | |
| TW201542590A (zh) | 具有改善的藥物動力學的抗ｃ５抗體 |